The Traderszone Network

Published in TZ Latest News 21 April, 2017 by The TZ Newswire Staff

Samsung Bioepis wins FDA approval for rheumatoid arthritis drug that competes with Johnson & Johnson

Samsung Bioepis has won U.S. regulatory approval for key biosimilar drug.